Harnessing the immune system and developing targeted vaccines: overall strategies of leveraging the body’s natural defense mechanisms to enhance cancer treatment

The immune system serves as a pivotal defense mechanism against foreign materials and abnormal cells, including cancer. Cancer immunotherapy exploits the immune system’s potential to target and eliminate malignant tumor cells, either through immunization or therapeutic antibodies. The presence of unusual antigens, such as GD2 and ErbB2, provides specific targets for immunotherapy. Next-generation immunotherapy, combining antibodies with immune-stimulatory cytokines, presents a promising avenue to enhance localized immune responses against tumors while minimizing systemic side effects. Challenges in cancer vaccine development include the diversity of tumor cells and their similarity to normal cells. Recent decades have seen significant progress in cancer vaccine development, with US Food and Drug Administration-approved therapeutic vaccines like Sipuleucel-T for prostate cancer and BCG for bladder cancer. However, challenges related to reproducibility and efficacy in cancer subjects persist. The current landscape of cancer treatment is undergoing a transformative shift, with combination therapies incorporating cytokines, tumor-associated antigens, and monoclonal antibodies becoming integral to treatment strategies. This dynamic approach reflects ongoing efforts to overcome challenges in developing effective therapeutic cancer vaccines and underscores the commitment to advancing the field. Advances in genomics allow for the development of personalized cancer vaccines tailored to an individual’s unique tumor profile, addressing the challenge of intratumoral heterogeneity. Combining cancer vaccines with other immunotherapies, such as immune checkpoint inhibitors, may enhance the overall anti-cancer immune response. Identifying and targeting neoantigens (mutated proteins specific to cancer cells) offers a more precise and selective approach to cancer vaccine development. These evolving strategies emphasize leveraging the body’s natural defense mechanisms to enhance the overall efficacy of cancer treatment, marking a departure from traditional approaches like surgery, chemotherapy, and radiation.